Editorial
Women spend nearly one-third of their life in menopause. [1] In this period, besides other comorbid conditions, women suffer from the onslaught of various musculoskeletal disorders also. One such problem is chronic low back pain (LBP) which is more prevalent in women than in men, and it also increases with age. [2] According to Dedicação et al. , about 70% of perimenopausal women have symptoms related to estrogen deficiency, such as vasomotor instability, sleep disorders, decreased bone mineral density, genitourinary atrophy, lipoprotein changes, and musculoskeletal pain, the latter being reported by more than half of the perimenopausal women. [3] Most studies show that women with a higher menopause symptom burden may be the most vulnerable for chronic back pain. [4] Despite this, little attention has been paid to pain in the spine/ low back ache and various problems of peripheral joints which are equally prevalent in this period of life. [5] A biopsychosocial model of chronic pain attributes sex differences in pain to interactions between biological, psychological, and sociocultural factors such as social class, low levels of education, and low income. [6] The heightened pain sensitivity among women can also partially explain greater reports of pain by women compared to men. [7] Population-based studies have shown that the prevalence of widespread pain increases with age, peaking in the seventh and eighth decades. Recently, it has been shown that genetics also plays a role in the development of LBP. [8] Estrogen participates in a variety of biological processes through different molecular mechanisms. Collagen wasting is commonly observed in bone and skin in the postmenopausal period due to decreased estrogen levels. [9] Hormone replacement therapy (HRT) has been shown to be protective against menopause-associated osteoarthritis. [2] However, in one study, Musgrave et al. [10] reported that women taking HRT suffered more back pain and back pain-related disability than did those not taking HRT. An in-depth understanding of the role of the gonadal hormones in LBP modulation remains unclear; whether HRT is useful for patients with severe LBP warrants further studies.
At some point in life, 36.4% to 58% of people in European countries and in the United States experience LBP. [11] This poses a great medical and socioeconomic challenge to such extent that some researchers call it a lifestyle disease. It is the main cause of absence in the workplace and the second cause of visiting primary health-care professionals. Spine pain has negative psychological consequences as it impairs daily functioning of the affected person. It also poses a serious socioeconomic Dr. Annil Mahajan Dr. Ranu Patni Dr. Somnath Verma
